IL6 and prostate cancer: In prostate cancer, tumor cells released IL-6 leading to fibroblasts activation, and in turn, fibroblasts, through MMPs secretion, elicited an EMT phenotype in cancer cells, as well as enhancement of tumor growth and development of spontaneous metastases.